Your browser doesn't support javascript.
loading
Positron emission tomography molecular imaging-based cancer phenotyping.
Jin, Chentao; Luo, Xiaoyun; Li, Xiaoyi; Zhou, Rui; Zhong, Yan; Xu, Zhoujiao; Cui, Chunyi; Xing, Xiaoqing; Zhang, Hong; Tian, Mei.
Afiliação
  • Jin C; Department of Nuclear Medicine and Positron Emission Tomography Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Luo X; Institute of Nuclear Medicine and Molecular Imaging, Zhejiang University, Hangzhou, China.
  • Li X; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Zhou R; Department of Nuclear Medicine and Positron Emission Tomography Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Zhong Y; Institute of Nuclear Medicine and Molecular Imaging, Zhejiang University, Hangzhou, China.
  • Xu Z; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Cui C; Department of Nuclear Medicine and Positron Emission Tomography Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Xing X; Institute of Nuclear Medicine and Molecular Imaging, Zhejiang University, Hangzhou, China.
  • Zhang H; Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, China.
  • Tian M; Department of Nuclear Medicine and Positron Emission Tomography Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Cancer ; 128(14): 2704-2716, 2022 07 15.
Article em En | MEDLINE | ID: mdl-35417604
ABSTRACT
During the past several decades, numerous studies have provided insights into biological characteristics of cancer cells and identified various hallmarks of cancer acquired in the tumorigenic processes. However, it is still challenging to image these distinctive traits of cancer to facilitate the management of patients in clinical settings. The rapidly evolving field of positron emission tomography (PET) imaging has provided opportunities to investigate cancer's biological characteristics in vivo. This article reviews the current status of PET imaging on characterizing hallmarks of cancer and discusses the future directions of PET imaging strategies facilitating in vivo cancer phenotyping.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tomografia por Emissão de Pósitrons / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tomografia por Emissão de Pósitrons / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China